Evidence map›Paper›PMID 33425155›Full record

ArticleThe Pan African medical journal2020

Prescription of pharmacotherapy and blood pressure control among hypertensive outpatients in two semi-urban hospitals in Cameroon: a cross-sectional study.

Anastase Dzudie, Messaline Fodom Fomo, Denis Georges Teuwafeu, Clovis Nkoke, Azabji Kenfack, Divine Tim Bonghaseh, Domin Ekaney, Amy Tantchou, Cabral Tantchou, Laurent Serges Etoundi Ngoa and 2 more

Abstract read
In one paragraph

Article in The Pan African medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anastase DzudieDepartment of Physiology, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon.
Messaline Fodom FomoClinical Research Education Networking and Consultancy (CRENC), Douala, Cameroon.
Denis Georges TeuwafeuDepartment of Internal Medicine, Buea Regional Hospital, Buea, Cameroon.
Clovis NkokeClinical Research Education Networking and Consultancy (CRENC), Douala, Cameroon.
Azabji KenfackDepartment of Physiology, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon.
Divine Tim BonghasehClinical Research Education Networking and Consultancy (CRENC), Douala, Cameroon.
Domin EkaneyClinical Research Education Networking and Consultancy (CRENC), Douala, Cameroon.
Amy TantchouMariner Finance, Maryland, USA.
Cabral TantchouShisong Cardiac Center, Kumbo, North West Region, Cameroon.
Laurent Serges Etoundi NgoaDepartment of Physiology, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon.
Andre Pascal KengneClinical Research Education Networking and Consultancy (CRENC), Douala, Cameroon.
Simeon Pierre ChoukemDepartment of Internal Medicine and Subspecialties, Douala General Hospital, Douala, Cameroon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionseveral international guidelines are available on drug treatment for hypertension, but the control of hypertension remains very poor in sub-Saharan Africa (SSA). We investigated the commonly prescribed antihypertensive drugs and their association with blood pressure (BP) control in adult Cameroonians.

methodswe consecutively recruited hypertensive outpatients attending the Buea and Limbe Regional Hospitals (southwest region of Cameroon). Controlled BP was defined as BP < 140/90mmHg in hypertensive patients aged 60 years or younger, diabetics or patients with chronic kidney disease or a BP < 150/90mmHg in non-diabetic hypertensive patients older than 60 years of age (JNC8).

resultsof the 408 participants included (mean age 61.1 years), 67% were female. The median duration of hypertension was 6 years and the median duration of the current treatment was 22 weeks. Commonly prescribed antihypertensives were calcium channel blockers (CCB, 35.1%), thiazide/thiazide-like diuretics (TD/TLD, 26.1%) and angiotensin-converting enzyme inhibitors (ACEI, 19.5%). The median monthly cost of antihypertensive was 10279.6 CFA (approximately equal to US$ 172). Seventy percent (70%) of participants were receiving at least 2 drugs, with ACEI+TD/TLD, CCB+TD/TLD, and ACEI+CCB+TD/TLD being the most frequent combination. The rate of BP control was 52% overall, and 60% in participants on monotherapy.

conclusionCCBs were the most prescribed single antihypertensive drugs in this setting while ACEI+TD/TLD was the most common combination. About half of patients were at target BP control levels Improving availability and affordability of these medications may improve hypertension management and control.

Indexed as

AdultAgedAged, 80 and overAntihypertensive AgentsBlood PressureCameroonCross-Sectional StudiesDrug CostsDrug Therapy, CombinationFemaleHospitals, UrbanHumansHypertensionMaleMiddle AgedOutpatientsAntihypertensive Agentsantihypertensive drugsblood pressureCameroonHypertension

Identifiers

PMID33425155
PMCPMC7755361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.